You are here: Industry Insights > study

News List

Amgen’s Nplate Approved for ITP contractpharma
December 18, 2018
Amgen received approval from the FDA for the supplemental Biologics License Application (sBLA) for Nplate (romiplostim) for the treatment of pediatric patients one year of age and older with immune thrombocytopenia (ITP) for at least six months who have h
Neurotrope Announces Publication of Phase 2 Alzheimer's Study contractpharma
December 18, 2018
Neurotrope Inc. announced that data from its Phase 2, multidose, exploratory trial evaluating Bryostatin-1 as a treatment of cognitive deficits in moderate to severe Alzheimer's disease were published online in the Journal of Alzheimer's Disease.
Janssen, OHCA Enter LAIs Contract contractpharma
December 17, 2018
Janssen Pharmaceuticals, Inc. has entered a results-based contract for long-acting injectable schizophrenia medicines (LAIs) with the Oklahoma Health Care Authority (OHCA), which manages Oklahoma's Medicaid plan, SoonerCare.
Needed vaccines unlikely at current funding levels, study says fiercepharma
December 12, 2018
Despite hundreds of pipeline programs in testing and billions of dollars spent annually...
Scientists weigh Zika challenge study: report fiercepharma
December 12, 2018
Zika captured the world's attention when microcephaly cases started popping up in Brazil back in 2015, and in a fast response, governments and industry quickly committed resources for vaccine research.
Purdue Pharma L.P. Announces Successful Completion of First-in-Human Study for Oncology Therapy Candidate Tinostamustine pharmafocusasia
December 03, 2018
Purdue Pharma L.P. today announced successful completion of a first-in-human Phase 1 dose escalation study of tinostamustine in patients with relapsed or refractory hematological malignancies for which there are no available therapies.
Biomarkers show responsiveness to endometriosis treatment europeanpharmaceuticalreview
October 31, 2018
Biomarkers could identify how women with endometriosis will respond to first-line treatment – progestin-based therapies such as oral contraceptives…
ActoBio Doses First Patient in Study of AG019 americanpharmaceuticalreview
October 30, 2018
ActoBio Doses First Patient in Study of AG019
Achieve Announces Study Results Demonstrating Similar Bioavailability for New Cytisine Formulation americanpharmaceuticalreview
September 28, 2018
Achieve Life Sciences announced results of a clinical study evaluating the effect of food on the bioavailability of a new formulation for cytisine.
Rates of vaccination decline in England, study shows pharmafile
September 20, 2018
The number of people who are receiving the 12 routine childhood vaccinations has declined in proportion to the eligible population according to figures published by NHS digital.

Previous page 1 2 3 4 5 Next page